Press-release for stocks in the wholesale trade sector for abvc

Prices are updated after-hours

sector : Wholesale trade symbols : Abvc

save search

AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -2.94% | O: -1.96% H: 0.0% C: 0.0%
life biopharma acquired

ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -11.61% | O: 2.68% H: 3.48% C: -11.3%
treatment biopharma royalties global for agreement

ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -18.85% | O: 5.74% H: 1.55% C: -11.63%
biopharma royalties global for

ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -5.71% | O: 33.81% H: 3.2% C: -8.9%
vitargus biopharma royalties global deal

AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
Published: 2024-03-21 (Crawled : 12:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -8.33% | O: -0.54% H: 3.33% C: -1.32%
million biopharma

ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
Published: 2024-03-19 (Crawled : 12:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -14.66% | O: -1.72% H: 0.0% C: 0.0%
ceo asia

ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Published: 2024-03-14 (Crawled : 13:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -19.51% | O: -0.81% H: 0.0% C: 0.0%
first business year update biopharma

ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -18.85% | O: 0.82% H: 0.0% C: 0.0%
cancer market

ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
Published: 2024-02-15 (Crawled : 13:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -21.43% | O: -0.4% H: 0.0% C: 0.0%
license biopharma royalties agreement

ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
Published: 2024-02-12 (Crawled : 13:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -25.0% | O: -0.76% H: 3.05% C: 2.29%
treatment biopharma

ABVC Acquires $2.96 Million Worth of Land in Asia with Stocks Priced at $3.50 per Share
Published: 2024-02-08 (Crawled : 14:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -29.29% | O: -0.71% H: 3.6% C: -6.47%
million asia

ABVC BioPharma and its Subsidiary Receive $460M From AiBtl BioPharma as the First Milestone Payment of Global Licensing Fees
Published: 2024-01-03 (Crawled : 12:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -18.18% | O: 79.33% H: 12.91% C: -11.06%
first payment biopharma global milestone

ABVC BioPharma Announces Completion of Subject Treatment for Interim Analysis on ADHD Phase IIb Clinical Study
Published: 2023-12-07 (Crawled : 13:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -26.67% | O: -1.48% H: 2.26% C: -6.02%
treatment biopharma adhd study

ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical Trials
Published: 2023-12-05 (Crawled : 13:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -28.26% | O: 5.07% H: 1.38% C: -0.69%
irwin cancer depression biopharma trials medical

ABVC BioPharma Receives U.S. Patent for ADHD Treatment, a $32 Billion Market
Published: 2023-11-21 (Crawled : 13:30) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -40.18% | O: 14.8% H: 16.84% C: -6.32%
patent biopharma adhd market

ABVC BioPharma Enters Definitive Agreement with Licensing Income Worth $467M and Royalties Up to $200M
Published: 2023-11-16 (Crawled : 15:00) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade

| -20.8% | O: -1.6% H: 44.72% C: 29.27%
biopharma royalties agreement

ABVC BioPharma Reports Third Quarter 2023 Financial and Operational Results
Published: 2023-11-15 (Crawled : 14:00) - globenewswire.com
ABVC | $0.9899 -5.72% -6.07% 160K

Wholesale Trade